Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
9(75.0%)
Phase 2
2(16.7%)
Phase 4
1(8.3%)
12Total
N/A(9)
Phase 2(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT06516939Not ApplicableRecruiting

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Role: lead

NCT04989361Not ApplicableUnknown

Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles.

Role: lead

NCT05245045Not ApplicableUnknown

Efficacy and Safety of STBF Photodynamic Therapy for Moderate and Severe Acne Vulgaris

Role: lead

NCT04709289Not ApplicableCompleted

Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study

Role: lead

NCT04167982Not ApplicableUnknown

Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for Moderate and Severe Acne Vulgaris

Role: lead

NCT04396184Not ApplicableUnknown

Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis

Role: lead

NCT03948321Not ApplicableUnknown

Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts

Role: lead

NCT03961607Not ApplicableUnknown

Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Moderate or Severe Acne

Role: lead

NCT03942185Phase 2Unknown

Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study

Role: collaborator

NCT03941431Phase 2Unknown

Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine

Role: collaborator

NCT03642535Phase 4Unknown

Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention

Role: lead

NCT03596619Not ApplicableUnknown

The Study of Plum-blossom Needling Enhancing Efficacy of Aminolevulinic Acid-photodynamic Therapy for Actinic Keratosis

Role: lead

All 12 trials loaded